These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35641914)

  • 1. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
    Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
    BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis.
    Flythe JE; Karlsson N; Sundgren A; Cordero P; Grandinetti A; Cremisi H; Rydén A
    BMC Nephrol; 2021 Jun; 22(1):233. PubMed ID: 34162354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Conceptual Model of Physical Functioning Limitations Experienced by Patients with Late-Stage Chronic Kidney Disease: A Qualitative Interview Study.
    Palmer E; Johar I; Little DJ; Karlsson N
    Adv Ther; 2024 Jul; 41(7):2757-2775. PubMed ID: 38722538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Nocturia Sleep Quality Scale: a patient-reported outcome measure of sleep impact related to nocturia.
    Romano CD; Lewis S; Barrett A; Andersson FL; Williams V; Ancoli-Israel S; Roth T
    Sleep Med; 2019 Jul; 59():101-106. PubMed ID: 31072693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
    Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
    J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving CKD-Specific Patient-Reported Measures of Health-Related Quality of Life.
    Ware JE; Richardson MM; Meyer KB; Gandek B
    J Am Soc Nephrol; 2019 Apr; 30(4):664-677. PubMed ID: 30898870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
    Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
    Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity.
    Hartford CA; Sherman SA; Karantzoulis S; Guillemin I; Phinney MG; Kelly KL; Negron KE; Raja SM; Rofail D
    Neurol Ther; 2023 Dec; 12(6):2079-2099. PubMed ID: 37747661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Impact of Nighttime Urination (INTU) questionnaire to assess the impact of nocturia on health and functioning.
    Abrams S; Martin S; Gillard KK; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1686-1692. PubMed ID: 29566269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Content Validity and Cognitive Debriefing of a Patient-Reported Outcome Instrument Evaluating Symptoms and Disease Impact in Patients with Geographic Atrophy.
    Morga A; Chamberlain CX; Meyers O; Roberts C; Gaspar L; Su J
    Ophthalmol Ther; 2023 Apr; 12(2):1181-1193. PubMed ID: 36781630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ).
    Becker B; Bracher M; Chauhan D; Rendas-Baum R; Lin X; Raymond K; O'Connor M; Kosinski M
    J Patient Rep Outcomes; 2021 Dec; 5(1):129. PubMed ID: 34894330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Health-Related Quality of Life in Chronic Kidney Disease Patients: A Hospital-Based Cross-Sectional Study.
    Sharma S; Kalra D; Rashid I; Mehta S; Maity MK; Wazir K; Gupta S; Ansari SA; Alruqi OS; Khan R; Khan I; Anwar S
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893506
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a Conceptual Model of Chronic Lymphocytic Leukemia to Better Understand the Patient Experience.
    Eek D; Blowfield M; Krogh C; Chung H; Eyre TA
    Patient; 2021 Jan; 14(1):75-87. PubMed ID: 32808103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.
    de la Orden Abad M; Haberland C; Karn H; Skalicky A; Hareendran A
    J Patient Rep Outcomes; 2023 Jul; 7(1):65. PubMed ID: 37428359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.
    van Haalen H; Jackson J; Spinowitz B; Milligan G; Moon R
    BMC Nephrol; 2020 Mar; 21(1):88. PubMed ID: 32143582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
    Lasch KE; Hassan M; Endicott J; Piault-Luis EC; Locklear J; Fitz-Randolph M; Pathak S; Hwang S; Jernigan K
    BMC Psychiatry; 2012 Apr; 12():34. PubMed ID: 22534028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.